# Assessment of Fetal Pancreatic Size and Maternal Serum Biomarkers in GDM

> **NCT05392231** · — · COMPLETED · sponsor: **Haseki Training and Research Hospital** · enrollment: 109 (actual)

## Conditions studied

- Gestational Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05392231
- **Lead sponsor:** Haseki Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-10
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-05-10
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05392231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05392231, "Assessment of Fetal Pancreatic Size and Maternal Serum Biomarkers in GDM". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05392231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*